This paper is in the following e-collection/theme issue:

RCTs - Pilots/Feasibility Studies (eHealth) (121)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49196, first published .
Short-Wavelength Light–Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial

Short-Wavelength Light–Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial

Short-Wavelength Light–Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial

Authors of this article:

Salvador Pastor-Idoate1, 2, 3, 4 Author Orcid Image ;   Milagros Mateos-Olivares2, 5 Author Orcid Image ;   Eva María Sobas1, 6 Author Orcid Image ;   Miguel Marcos7, 8 Author Orcid Image ;   Alfredo Toribio9 ;   José Carlos Pastor1, 3, 4 Author Orcid Image ;   Ricardo Usategui Martín1, 10 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics

Journals

  1. Amado P, Amado S. Cromosome X-linked pigmentary retinosis. Oftalmología Clínica y Experimental 2024;17(03):e408 View
  2. Ghosh S, Parua P, Jana K, Ghosh S, Ghosh A, Debnath B, Halder J, Sahoo R, Rai V, Dash P, Das C, Kar B, Ghosh G, Rath G. Recent advances of novel nanoformulations combatting blue light hazards in the retina. Experimental Eye Research 2026;264:110806 View
  3. Hong W. Mitigating Blue-Light Risk in Display-Based Digital Therapeutics: A Practical Framework to Support Clinical Efficacy. Journal of Clinical Medicine 2026;15(4):1371 View